The concept behind The Insides™ System was originally conceived by Professor Ian Bissett in the 1980s from his time as a general surgeon in Nepal, where there was limited access to surgery.
During this experience, he observed an unmet clinical need in patients who were severely malnourished as a result of intestinal failure.
The Insides™ Company’s mission is to provide universal access to chyme reinfusion therapy through revolutionary products and education to establish a new standard of care.
The Insides™ Company develops life-changing medical devices for people who are recovering from severe intestinal conditions including inflammatory bowel disease, colorectal cancer and intestinal fistulas. Our mission is to empower patients to take control of their condition.
Dennis was co-founder & CEO of Rebis, which was acquired for $60M. Dennis then led commercialization at Cyra Technologies which was acquired in 2001 for $150m. On returning to NZ, Dennis spent 10 years as a General Partner of the Endeavour-icap VC fund. Dennis is a founding partner of Tuhua Ventures.
Garth has 30 years’ experience in the high-technology sector including 20 years in medical technology CEO roles. Prior to The Insides Co, Garth founded and grew digital therapeutics company Adherium (ASX：ADR). Garth has strong experience in leading global sales and technology licensing and has established operations and built teams in North America, Europe, Australasia and Asia. MSc, Physics 1st Class Honours.
Founder & Chief Medical Officer
Ian is a Professor of Colorectal Surgery, and adult lead of the NZ National Intestinal Failure Service - a key opinion leader. Ian has been an international pioneer of nutrient recycling and is passionate about advancing our technologies.
Executive Director, Founder & Chief Scientific Officer
Greg is a Consultant Colorectal Surgeon at the ADHB and Associate Professor at University of Auckland. He has extensive leadership experience, holds a PhD in biomedical engineering and has a passion for developing breakthrough medical devices.
Executive Director, Founder & Chief Operation Officer
John holds a PhD in biomedical engineering, which he utilizes to bridge the gap between the medical and engineering world. He has a background in clinical collaboration and operations optimization.
Executive Director, Founder & Chief Technology Officer
Rob has a background in mechanical engineering, entrepreneurial businesses and developing disruptive technologies. He holds several patents and design awards for previous work.
Quality, Regulatory & Sustainability Manager
Tina has 25 years regulatory and quality experience with leading healthcare companies including Fisher & Paykel Healthcare, Arjo, and Adherium.
Business Development Manager EU
Duncan has a technical background in Science (BSc) and Engineering (BEng Hons) with a passionate focus on the medical device industry. He has worked in numerous medical device companies, spanning solutions for intestinal failure, respiratory conditions, pelvic floor conditions, and prosthetics. He has helped design, test and commercialize these products and has an in-depth knowledge of the medical device field from his experience.
Country Sales Manager - New Zealand
William has a background in human physiology and science enterprise. His experience in technology transfer and commercialisation of a portfolio of different medical technologies enables him to be fully involved in the sales and marketing activities for The Insides Company's breakthrough medical technologies.
Gil is an active member of several international nutrition societies, including ASPEN (USA), ESPEN (Europe), FELANPE (Latin America) and has been a council member of BAPEN (UK), the Nutrition Societies of UK and NZ and was vice-president of the Australasian Society of Parenteral & Enteral Nutrition (AuSPEN). He is a past chairman of the British Pharmaceutical Nutrition Group and remains Editor of the quarterly newsletter ‘Feeding Times’.
Non-Executive Director - Regulatory
Nancy is the former Managing Director of Brandwood Biomedical NZ a premium New Zealand regulatory affairs consultancy. She was an original investor and part of the early development team of Aroa Biosurgery and has an extensive background in medical devices, operations and regulatory compliance. She sits on several medical technology boards.
Douglas brings 20+ years of international experience in the MedTech and Life Sciences industries. In 2016 Douglas led the US$1.8 billion capital raise of ConvaTec by way of an IPO on the London Stock Exchange. Prior to the IPO, Douglas led and had P&L responsibility for ConvaTec’s global Ostomy business.
Anthony has had 30 plus years’ experience in sales, marketing, and senior management in the medical device market for both global and SME healthcare organisations providing products and services to health providers around the world.
We have openings at offices all around the world. If there isn’t an opening in your area, get in touch, we are always on the lookout for great talent.
This role encompasses the design, development, management, and on-going support of medical devices introduced to the market by The Insides Company.Get in touch